government and policy
A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.
"It's a positive moment," says Kyle Zebley, ATA's CEO and executive director of ATA Action, in a conversation about health tech policy advances and the organization's strategies for 2026.
HIMSS23
ONC senior advisor and innovation portfolio lead Stephen Konya, Moffitt Cancer Center VP of digital innovation Santosh Mohan and the Digital Medicine Society CEO Jennifer Goldsack describe their CancerX partnership.
The function that allows those to claim the support wasn't added to the app.